This information was published on 2026-05-14T11:25:40 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2454294 (IR 1791452) |
| (220) |
18 Mar 2024
|
| (300) |
US, 02 Oct 2023, 98205862
|
| (511) (510) |
Class 10
Medical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body causing tumor cell lysis; medical apparatus, namely, infusion and injection devices for locally targeted drug administration. |
| (540) | ACCULYSE |
| (550) | Word |
| (730) |
Syncromune, Inc.
|
| (750) |
Mallesons
|
Find out more about publications on the About page.